OncoLink at ASCO 1996: Monday, May 20

photo of Zhao Yu Pei and Shi Ting Zhang, Beijing, China

Photo (l to r): Zhao Yu Pei, PUMC Hospital, Beijing, China
Shi Ting Zhang, General Hospital of PLA, Beijing, China

Advances in Supportive Care Offer New Opportunities for Oncology Patients and Clinicians
American Society of Clinical Oncology Announces Research Awards
American Society of Clinical Oncology Announces Research Awards
Combined Modality Therapy Shows Improvements in Survival for Certain Cancer Patients
Interferon Plus Chemotherapy Is Better Than Chemotherapy Alone In Renal Cell Cancer
Interferon Plus Interleukin-2 Is The Optimal Treatment To Induce Responses In Metastatic Renal Cell Cancer
James O. Armitage, M.D., Assumes ASCO Presidency
John H. Glick, MD Gives Presidential Address
Long-Term Survival Following Immunization with BEC2 Plus BCG after Initial Therapy for Small Cell Lung Cancer
Randomized Trial Of 2 Vs. 5 Years Of Adjuvant Tamoxifen In Postmenopausal Women With Early-Stage Breast Cancer
Research Presented Helps to Define Best Use and Timing of Bone Marrow Transplantation

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More

OncoLink Cancer Treatment and Resources